Acknowledgements This work was supported by American Cancer Society grant number DICRIDG-22103719901, National Science Foundation grant number 1912322, and National Institutes of Health grant R25AG070244 to Manoj Mishra
Enter your health details into the calculator
Real-world Evidence on the Utilization, Clinical and Comparative Effectiveness, and Adverse Effects of Newer GLP-1RA-based Weight-loss Therapies
Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR, Colorectal Cancer Study G
Pediatric admission forms contain places to document both a Dosing Weight and a Measured Weight
UK approves first weight-loss tablet as Wegovy pill cleared for patients with obesity Love Ballymena Jun 11 3 min read A major new weight-loss treatment has been approved for use in the UK, marking the first time a GLP-1 receptor agonist tablet has been authorised for weight management rather than requiring injections